Brands: Arava · Leflunomide
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Zydus Lifesciences Limited | generic | 6 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 6 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 5 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 3 | SUPPLYING |
| Burel Pharmaceuticals, LLC | unknown | 2 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 2 | SUPPLYING |
| A-S Medication Solutions | repackager | 2 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 2 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Leflunomide Tablet — reported in shortage by Sanofi-Aventis U.S. LLC. Therapeutic category: Rheumatology.
Leflunomide Tablet — reported in shortage by Sanofi-Aventis U.S. LLC. Therapeutic category: Rheumatology.
